Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1984 Sep;47(9):1002–1008. doi: 10.1136/jnnp.47.9.1002

EMG patterns in abnormal involuntary movements induced by neuroleptics.

N Bathien, R M Koutlidis, P Rondot
PMCID: PMC1028005  PMID: 6148381

Abstract

Electromyographic (EMG) activity of abnormal involuntary movements and their modifications after Piribedil, a dopaminergic agonist, were analysed in patients presenting with tremor or tardive dyskinesia induced by treatment with neuroleptics. Quantitative analysis of EMG bursts and of their phase relationships with bursts of antagonist muscles revealed differences between tremor and tardive dyskinesia; three separate EMG types of the latter were found. In tremor, EMG activity was coordinated between agonists and antagonists. Length and frequency of bursts are characteristic. In tardive dyskinesia, phase histograms of antagonist muscle bursts showed an absence of reciprocal organisation of EMG activity. This activity was made up of either rhythmical bursts (type I and II according to the frequency) or irregular discharges (type III). Piribedil decreased tremor but facilitated EMG activity in tardive dyskinesia. These results give an objective measurement or classification of tremor and tardive dyskinesia induced by neuroleptics.

Full text

PDF
1002

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bathien N., Rondot P., Koutlidis R. M. Neurophysiologie clinique des dyskinésies tardives post-neuroleptiques et des dyskinésies dopa-induites de la maladie de Parkinson. J Physiol (Paris) 1981 Apr;77(1):131–141. [PubMed] [Google Scholar]
  2. Clow A., Jenner P., Marsden C. D. Changes in dopamine-mediated behaviour during one year's neuroleptic administration. Eur J Pharmacol. 1979 Aug 15;57(4):365–375. doi: 10.1016/0014-2999(79)90499-0. [DOI] [PubMed] [Google Scholar]
  3. Clow A., Theodorou A., Jenner P., Marsden C. D. Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal. Adv Biochem Psychopharmacol. 1980;24:335–340. [PubMed] [Google Scholar]
  4. Crane G. E. Persistent dyskinesia. Br J Psychiatry. 1973 Apr;122(569):395–405. doi: 10.1192/bjp.122.4.395. [DOI] [PubMed] [Google Scholar]
  5. DELAY J., DENIKER P., GREEN A., MORDRET M. Le syndrome excito-moteur provoqué par les médicaments neuroleptiques. Presse Med. 1957 Nov 2;65(79):1771–1774. [PubMed] [Google Scholar]
  6. Goetz C. G., Weiner W. J., Nausieda P. A., Klawans H. L. Tardive dyskinesia: pharmacology and clinical implications. Clin Neuropharmacol. 1982;5(1):3–22. [PubMed] [Google Scholar]
  7. Iansek R., Porter R. The monkey globus pallidus: neuronal discharge properties in relation to movement. J Physiol. 1980 Apr;301:439–455. doi: 10.1113/jphysiol.1980.sp013216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kuo J. S., Carpenter M. B. Organization of pallidothalamic projections in the rhesus monkey. J Comp Neurol. 1973 Oct 1;151(3):201–236. doi: 10.1002/cne.901510302. [DOI] [PubMed] [Google Scholar]
  9. Rondot P., Bathien N. Mouvements anormaux induits par les médicaments psychotropes. Encephale. 1979;5(1):41–48. [PubMed] [Google Scholar]
  10. Rondot P., Dumas R. J. Dopamine et mouvements anormaux. Rev Neurol (Paris) 1972 Jul;127(1):99–113. [PubMed] [Google Scholar]
  11. SIGWALD J., BOUTTIER D., RAYMONDEAUD C., PIOT C. [4 Cases of facio-bucco-linguo-masticatory dyskinesis of prolonged development following treatment with neuroleptics]. Rev Neurol (Paris) 1959 Jun;100:751–755. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES